Composition for treating pathology associated with MSRV/HERV-W

Details for Australian Patent Application No. 2005214107 (hide)

Owner Institut National de la Sante et de la Recherche Medicale (I.N.S.E.R.M.) BioMerieux

Inventors Jouvin-Marche, Evelyne; Marche, Patrice; Rolland, Alexandre; Perron, Herve

Agent Mallesons

Pub. Number AU-A-2005214107

PCT Pub. Number WO2005/080437

Priority 0400675 23.01.04 FR

Filing date 24 January 2005

Wipo publication date 1 September 2005

International Classifications

C07K 16/10 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

27 July 2006 PCT application entered the National Phase

  PCT publication WO2005/080437 Priority application(s): WO2005/080437

30 October 2008 Alteration of Name

  The name of the applicant has been altered to Institut National de la Sante et de la Recherche Medicale (I.N.S.E.R.M.); bioMerieux

11 March 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005214115-Galanin receptors and brain injury

2005214102-Method for detecting PrP using a molecule containing at least one positive charge and/or at least one osidic bond and a ligand other than a proteinic ligand